Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims
Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of PROCEPT BioRobotics (NASDAQ: PRCT) against certain of its officers and directors for alleged breaches of fiduciary duty. The firm points to a previously filed class action alleging that, between February 28, 2024 and February 25, 2026, defendants made misleading statements about PROCEPT's business and financial condition, and that the company used an undisclosed discount program to encourage bulk handpiece orders beyond procedure demand — pulling forward sales, inflating reported revenue, and creating more than 10,000 units of excess customer inventory.
Key figures
- Class period end
- 2026-02-25
- Class period start
- 2024-02-28
- Excess inventory units
- more than 10,000
- Shareholder eligibility cutoff
- prior to February 28, 2024
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.